Posted inChinese Technology and Innovation
China’s Biotech Boom: Where the Money Is Going — and the US-China Friction Points
Chinese drugmakers licensed out over $139 billion of innovations in 2026 — already a record year. The money is flowing to oncology, obesity, and autoimmune drugs, while Washington's BIOSECURE Act moves toward restrictions. Where the money goes, and what could stop it.









